ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,555.74
-0.16%
US Tech 100
19,095.20
-1.02%
Dow Jones
40,358.09
-0.14%
Brent Oil
80.445
-0.41%
Bitcoin
65,840.15
-0.13%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Cue Biopharma Inc (CUE)

  7. Cue Biopharma Inc (CUE) News

CUE

Cue Biopharma (CUE)

Cue Biopharma Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CUE
DateTimeSourceHeadlineSymbolCompany
06/07/20244:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CUECue Biopharma Inc
06/07/20244:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CUECue Biopharma Inc
06/07/20244:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CUECue Biopharma Inc
06/07/20244:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CUECue Biopharma Inc
06/07/20244:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CUECue Biopharma Inc
06/04/20248:00AMGlobeNewswire Inc.Cue Biopharma Presents Updated Data from Phase 1 Trial of CUE-101 in Recurrent/Metastatic HPV+ Head and Neck Cancer at the 2024 ASCO Annual MeetingNASDAQ:CUECue Biopharma Inc
06/03/20248:00AMGlobeNewswire Inc.Cue Biopharma to Present at Two Upcoming Investor Healthcare Conferences in June 2024NASDAQ:CUECue Biopharma Inc
05/24/20244:00PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:CUECue Biopharma Inc
05/09/20244:05PMGlobeNewswire Inc.Cue Biopharma Reports First Quarter 2024 Financial Results and Recent Business HighlightsNASDAQ:CUECue Biopharma Inc
05/09/20244:01PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CUECue Biopharma Inc
05/09/20244:00PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CUECue Biopharma Inc
05/08/20248:00AMGlobeNewswire Inc.Cue Biopharma to Present at the 20th Annual PEGS Boston SummitNASDAQ:CUECue Biopharma Inc
05/07/20248:00AMGlobeNewswire Inc.Cue Biopharma to Participate in Fireside Chat at The Citizens JMP Life Sciences ConferenceNASDAQ:CUECue Biopharma Inc
04/24/202410:01AMGlobeNewswire Inc.Cue Biopharma to Present at the 2024 American Society of Clinical Oncology (ASCO) Annual MeetingNASDAQ:CUECue Biopharma Inc
04/08/20244:05PMGlobeNewswire Inc.Cue Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results and Updated Business HighlightsNASDAQ:CUECue Biopharma Inc
04/02/20248:00AMGlobeNewswire Inc.Cue Biopharma to Host Business Update Call and WebcastNASDAQ:CUECue Biopharma Inc
03/08/20244:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CUECue Biopharma Inc
03/08/20244:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CUECue Biopharma Inc
03/08/20244:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CUECue Biopharma Inc
03/08/20244:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CUECue Biopharma Inc
02/29/202410:00AMGlobeNewswire Inc.Cue Biopharma’s Lead Clinical Asset, CUE-101, to be Featured at the 2024 Multi-disciplinary Head and Neck Cancers SymposiumNASDAQ:CUECue Biopharma Inc
02/22/20244:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CUECue Biopharma Inc
02/06/20248:00AMGlobeNewswire Inc.Cue Biopharma to Present Corporate Update at the Oppenheimer 34th Annual Healthcare Life Sciences ConferenceNASDAQ:CUECue Biopharma Inc
01/04/20244:02PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CUECue Biopharma Inc
01/04/20244:01PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CUECue Biopharma Inc
01/04/20244:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CUECue Biopharma Inc
11/22/20238:00AMGlobeNewswire Inc.Cue Biopharma to Present at the JMP Securities Hematology and Oncology SummitNASDAQ:CUECue Biopharma Inc
11/09/20234:05PMGlobeNewswire Inc.Cue Biopharma Reports Third Quarter 2023 Financial Results and Recent Business HighlightsNASDAQ:CUECue Biopharma Inc
11/07/20238:00AMGlobeNewswire Inc.Cue Biopharma to Present at Three Upcoming Investor Healthcare Conferences in NovemberNASDAQ:CUECue Biopharma Inc
11/03/20234:15PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CUECue Biopharma Inc
 Showing the most relevant articles for your search:NASDAQ:CUE

Your Recent History

USOTC
NWPN
Now (PK)
USOTC
KEGS
1812 Brewing (PK)
USOTC
KBLB
Kraig Biocraft Laborator... (QB)
USOTC
RONN
Ronn Motor (PK)
USOTC
ITUP
Interups (CE)
USOTC
ENZC
Enzolytics (PK)
USOTC
AABB
Asia Broadband (PK)
NASDAQ
TSLA
Tesla
NYSE
AMC
AMC Entertainment
NASDAQ
NB
NioCorp Developments
USOTC
IDVV
International Endeavors (PK)
USOTC
ECSL
Ecare Solutions (PK)
USOTC
SPZI
Spooz (PK)
NASDAQ
COOP
Mr Cooper
USOTC
SMCE
SMC Entertainment (PK)
USOTC
LQMT
Liquidmetal Technologies (QB)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved